Search

Peter D. Le

Examiner (ID: 14873, Phone: (571)270-5382 , Office: P/2488 )

Most Active Art Unit
2488
Art Unit(s)
2488
Total Applications
777
Issued Applications
611
Pending Applications
73
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9068106 [patent_doc_number] => 20130259862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS' [patent_app_type] => utility [patent_app_number] => 13/844818 [patent_app_country] => US [patent_app_date] => 2013-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 7479 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13844818 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/844818
ANTIBODY-MEDIATED TRANSDUCTION OF HEAT SHOCK PROTEINS INTO LIVING CELLS Mar 15, 2013 Abandoned
Array ( [id] => 9383357 [patent_doc_number] => 20140086838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'IDENTIFICATION OF A NEW MOLECULAR FACTOR FOR EARLY DIAGNOSIS OF UROTHELIAL CARCINOMA OF THE BLADDER' [patent_app_type] => utility [patent_app_number] => 14/115259 [patent_app_country] => US [patent_app_date] => 2012-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5646 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14115259 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/115259
IDENTIFICATION OF A NEW MOLECULAR FACTOR FOR EARLY DIAGNOSIS OF UROTHELIAL CARCINOMA OF THE BLADDER May 1, 2012 Abandoned
Array ( [id] => 6389845 [patent_doc_number] => 20100317834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'IgG Immunoglobulin Variants with Optimized Effector Function' [patent_app_type] => utility [patent_app_number] => 12/862583 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 67887 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317834.pdf [firstpage_image] =>[orig_patent_app_number] => 12862583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/862583
IgG Immunoglobulin Variants with Optimized Effector Function Aug 23, 2010 Abandoned
Array ( [id] => 6062026 [patent_doc_number] => 20110200552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'CYTOKINE DESIGN' [patent_app_type] => utility [patent_app_number] => 12/744069 [patent_app_country] => US [patent_app_date] => 2008-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 17534 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200552.pdf [firstpage_image] =>[orig_patent_app_number] => 12744069 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/744069
CYTOKINE DESIGN Nov 20, 2008 Abandoned
Array ( [id] => 6534580 [patent_doc_number] => 20100204100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'BIOLOGICAL AGENTS ACTIVE IN CENTRAL NERVOUS SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/596330 [patent_app_country] => US [patent_app_date] => 2008-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11616 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204100.pdf [firstpage_image] =>[orig_patent_app_number] => 12596330 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/596330
BIOLOGICAL AGENTS ACTIVE IN CENTRAL NERVOUS SYSTEM Apr 16, 2008 Abandoned
Array ( [id] => 6440551 [patent_doc_number] => 20100104502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 12/513826 [patent_app_country] => US [patent_app_date] => 2007-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32021 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104502.pdf [firstpage_image] =>[orig_patent_app_number] => 12513826 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/513826
COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ENDOTHELIAL DYSFUNCTION Nov 5, 2007 Abandoned
Array ( [id] => 5010400 [patent_doc_number] => 20070280879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Therapeutic Use Of Rm1 Antigen' [patent_app_type] => utility [patent_app_number] => 10/592401 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15659 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280879.pdf [firstpage_image] =>[orig_patent_app_number] => 10592401 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592401
Therapeutic Use Of Rm1 Antigen Mar 10, 2005 Abandoned
95/000037 LARGE ANIMAL MODEL OF INVASIVE PULMONARY ASPERGILLOSIS IN AN IMMUNOCOMPROMISED HOST Feb 24, 2004 Issued
Array ( [id] => 7004608 [patent_doc_number] => 20050169921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Method of treating hemolytic disease' [patent_app_type] => utility [patent_app_number] => 10/771552 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8734 [patent_no_of_claims] => 171 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169921.pdf [firstpage_image] =>[orig_patent_app_number] => 10771552 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771552
Method of treating hemolytic disease Feb 2, 2004 Abandoned
Array ( [id] => 706729 [patent_doc_number] => 07060268 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Protein formulation' [patent_app_type] => utility [patent_app_number] => 10/428728 [patent_app_country] => US [patent_app_date] => 2003-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 17420 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060268.pdf [firstpage_image] =>[orig_patent_app_number] => 10428728 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/428728
Protein formulation May 1, 2003 Issued
Array ( [id] => 6721327 [patent_doc_number] => 20030055017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Growth hormone releasing hormone expression system and methods of use, including use in animals' [patent_app_type] => new [patent_app_number] => 10/124759 [patent_app_country] => US [patent_app_date] => 2002-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23816 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055017.pdf [firstpage_image] =>[orig_patent_app_number] => 10124759 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/124759
Growth hormone releasing hormone expression system and methods of use, including use in animals Apr 15, 2002 Abandoned
Array ( [id] => 6688884 [patent_doc_number] => 20030032609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Methods of modulating of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/121235 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12014 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032609.pdf [firstpage_image] =>[orig_patent_app_number] => 10121235 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/121235
Methods of modulating of angiogenesis Apr 11, 2002 Abandoned
09/980372 Spliceosome protein and its use Apr 3, 2002 Abandoned
Array ( [id] => 6870121 [patent_doc_number] => 20030082810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Methods for generating insulin-secreting cells suitable for transplantation' [patent_app_type] => new [patent_app_number] => 10/090011 [patent_app_country] => US [patent_app_date] => 2002-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17121 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082810.pdf [firstpage_image] =>[orig_patent_app_number] => 10090011 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/090011
Methods for generating insulin-secreting cells suitable for transplantation Feb 25, 2002 Abandoned
Array ( [id] => 6774198 [patent_doc_number] => 20030017536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Novel polypeptide' [patent_app_type] => new [patent_app_number] => 10/055106 [patent_app_country] => US [patent_app_date] => 2002-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3569 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017536.pdf [firstpage_image] =>[orig_patent_app_number] => 10055106 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/055106
Novel polypeptide Jan 22, 2002 Abandoned
Array ( [id] => 6661232 [patent_doc_number] => 20030135876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Maintenance of genetic lines using cryopreserved sperm' [patent_app_type] => new [patent_app_number] => 10/051956 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6877 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20030135876.pdf [firstpage_image] =>[orig_patent_app_number] => 10051956 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/051956
Maintenance of genetic lines using cryopreserved sperm Jan 15, 2002 Abandoned
Array ( [id] => 6720827 [patent_doc_number] => 20030054515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Protein-protein interactions' [patent_app_type] => new [patent_app_number] => 10/024595 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12113 [patent_no_of_claims] => 160 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054515.pdf [firstpage_image] =>[orig_patent_app_number] => 10024595 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/024595
Protein-protein interactions Dec 20, 2001 Abandoned
Array ( [id] => 6016928 [patent_doc_number] => 20020103155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Vectors for the expression of FGF-5 in human cells and uses thereof' [patent_app_type] => new [patent_app_number] => 10/023592 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6712 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103155.pdf [firstpage_image] =>[orig_patent_app_number] => 10023592 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/023592
Vectors for the expression of FGF-5 in human cells and uses thereof Dec 16, 2001 Abandoned
Array ( [id] => 6381121 [patent_doc_number] => 20020119929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Can1 and its role in mammalian infertility' [patent_app_type] => new [patent_app_number] => 10/003806 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24822 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119929.pdf [firstpage_image] =>[orig_patent_app_number] => 10003806 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/003806
Can1 and its role in mammalian infertility Nov 1, 2001 Abandoned
09/913279 Screening method with the use of mouse suffering from neuropilin 1 gene function disruption Oct 28, 2001 Abandoned
Menu